153 related articles for article (PubMed ID: 31037627)
1. Ability of Periostin as a New Biomarker of Idiopathic Pulmonary Fibrosis.
Okamoto M; Izuhara K; Ohta S; Ono J; Hoshino T
Adv Exp Med Biol; 2019; 1132():79-87. PubMed ID: 31037627
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.
Ohta S; Okamoto M; Fujimoto K; Sakamoto N; Takahashi K; Yamamoto H; Kushima H; Ishii H; Akasaka K; Ono J; Kamei A; Azuma Y; Matsumoto H; Yamaguchi Y; Aihara M; Johkoh T; Kawaguchi A; Ichiki M; Sagara H; Kadota JI; Hanaoka M; Hayashi SI; Kohno S; Hoshino T; Izuhara K;
PLoS One; 2017; 12(3):e0174547. PubMed ID: 28355256
[TBL] [Abstract][Full Text] [Related]
3. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
Naik PK; Bozyk PD; Bentley JK; Popova AP; Birch CM; Wilke CA; Fry CD; White ES; Sisson TH; Tayob N; Carnemolla B; Orecchia P; Flaherty KR; Hershenson MB; Murray S; Martinez FJ; Moore BB;
Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(12):L1046-56. PubMed ID: 23043074
[TBL] [Abstract][Full Text] [Related]
4. Periostin plays a critical role in the cell cycle in lung fibroblasts.
Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
[TBL] [Abstract][Full Text] [Related]
5. The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis.
Carpagnano GE; Soccio P; Scioscia G; Palladino GP; Foschino Barbaro MP; Lacedonia D
Rejuvenation Res; 2021 Aug; 24(4):302-306. PubMed ID: 33749341
[TBL] [Abstract][Full Text] [Related]
6. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis.
Tajiri M; Okamoto M; Fujimoto K; Johkoh T; Ono J; Tominaga M; Azuma K; Kawayama T; Ohta S; Izuhara K; Hoshino T
Respir Investig; 2015 Mar; 53(2):73-81. PubMed ID: 25745852
[TBL] [Abstract][Full Text] [Related]
7. Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis.
Nanri Y; Nunomura S; Terasaki Y; Yoshihara T; Hirano Y; Yokosaki Y; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Conway SJ; Izuhara K
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):204-216. PubMed ID: 31505128
[TBL] [Abstract][Full Text] [Related]
8. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.
Uchida M; Shiraishi H; Ohta S; Arima K; Taniguchi K; Suzuki S; Okamoto M; Ahlfeld SK; Ohshima K; Kato S; Toda S; Sagara H; Aizawa H; Hoshino T; Conway SJ; Hayashi S; Izuhara K
Am J Respir Cell Mol Biol; 2012 May; 46(5):677-86. PubMed ID: 22246863
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis.
Tomaru A; Kobayashi T; Hinneh JA; Baffour Tonto P; D'Alessandro-Gabazza CN; Fujimoto H; Fujiwara K; Takahashi Y; Ohnishi M; Yasuma T; Nishihama K; Yoshino M; Takao K; Toda M; Totoki T; Takei Y; Yoshikawa K; Taguchi O; Gabazza EC
Gene Ther; 2017 Nov; 24(11):706-716. PubMed ID: 28820502
[TBL] [Abstract][Full Text] [Related]
10. Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer.
Yamato H; Kimura K; Fukui E; Kanou T; Ose N; Funaki S; Minami M; Shintani Y
Sci Rep; 2021 Oct; 11(1):21114. PubMed ID: 34702952
[TBL] [Abstract][Full Text] [Related]
11. The role of periostin in lung fibrosis and airway remodeling.
O'Dwyer DN; Moore BB
Cell Mol Life Sci; 2017 Dec; 74(23):4305-4314. PubMed ID: 28918442
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
13. A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib.
Okamoto M; Fujimoto K; Johkoh T; Kawaguchi A; Mukae H; Sakamoto N; Ogura T; Ikeda S; Kondoh Y; Yamano Y; Komiya K; Umeki K; Nishikiori H; Tanino Y; Tsuda T; Arai N; Komatsu M; Sakamoto S; Yatera K; Inoue Y; Miyazaki Y; Hashimoto S; Shimizu Y; Hozumi H; Ohnishi H; Handa T; Hattori N; Kishaba T; Kato M; Inomata M; Ishii H; Hamada N; Konno S; Zaizen Y; Azuma A; Suda T; Izuhara K; Hoshino T
Sci Rep; 2023 Dec; 13(1):22977. PubMed ID: 38151520
[TBL] [Abstract][Full Text] [Related]
14. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
15. Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis.
Cameli P; Bergantini L; D'alessandro M; Vietri L; Refini RM; Pieroni M; Sestini P; Bargagli E
Minerva Med; 2020 Aug; 111(4):324-329. PubMed ID: 31755669
[TBL] [Abstract][Full Text] [Related]
16. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.
Okamoto M; Hoshino T; Kitasato Y; Sakazaki Y; Kawayama T; Fujimoto K; Ohshima K; Shiraishi H; Uchida M; Ono J; Ohta S; Kato S; Izuhara K; Aizawa H
Eur Respir J; 2011 May; 37(5):1119-27. PubMed ID: 21177844
[TBL] [Abstract][Full Text] [Related]
17. Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis.
Nakahara Y; Hashimoto N; Sakamoto K; Enomoto A; Adams TS; Yokoi T; Omote N; Poli S; Ando A; Wakahara K; Suzuki A; Inoue M; Hara A; Mizutani Y; Imaizumi K; Kawabe T; Rosas IO; Takahashi M; Kaminski N; Hasegawa Y
Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34049947
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
[TBL] [Abstract][Full Text] [Related]
20. Practical Application of Periostin as a Biomarker for Pathological Conditions.
Kii I
Adv Exp Med Biol; 2019; 1132():195-204. PubMed ID: 31037636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
